查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1747141

日本心血管设备市场规模、份额、趋势及预测（按设备类型、应用、最终用户和地区），2025 年至 2033 年

Japan Cardiovascular Devices Market Size, Share, Trends and Forecast by Device Type, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本心血管设备市场规模达330万美元。展望未来， IMARC Group预计到2033年，该市场规模将达到701万美元，2025-2033年期间的复合年增长率（CAGR）为8.08%。人口老化、心血管疾病发生率上升以及技术进步是推动市场发展的因素。关键细分市场包括心律调节器、支架和监测设备。政府措施和不断增加的医疗保健投资支撑着市场成长，而监管政策则影响产品的审批和应用。

日本心血管设备市场趋势：

微创心血管手术需求不断成长

由于人口老化和导管治疗技术的进步，日本对微创 (MI) 心血管设备的需求日益增长。经导管主动脉瓣置换术 (TAVR) 和经皮冠状动脉介入治疗 (PCI) 的采用率正在上升，这减少了住院时间并加快了患者康復。日本医疗器材公司正在投资机器人辅助手术和下一代导管，以提高精准度。在日本药品和医疗器材综合机构 (PMDA) 的指导下，监管环境正在简化突破性技术的审批，从而加快市场准入。此外，人工智慧 (AI) 正在提高心血管影像诊断的精准度，协助早期介入方案的发展。例如，2024 年 9 月，总部位于日本的 Cardio Intelligence 公司推出了 SmartRobin AI，这是一款由可解释的人工智慧驱动的心电图监测系统，可快速检测心房颤动，从而提高中风风险评估和心血管护理诊断的准确性。此外，随着政府对家庭医疗保健的支持，穿戴式心电图仪和植入式循环记录器等远端监测设备也越来越受欢迎。这一趋势符合日本「价值导向医疗」的理念，强调成本效益和病患治疗效果。随着报销政策的转变，市场可望预期微创心血管解决方案将迎来成长。

人工智慧整合心血管诊断的成长

人工智慧正在改变日本的心血管诊断，改善早期疾病检测和预测分析。人工智慧驱动的超音波心动图和电脑断层扫描 (CT) 成像仪能够更快、更准确地诊断心臟病。大型研究中心和医院正在应用人工智慧即时监测心臟，减轻医护人员的负担。机器学习技术正被整合到电子健康记录 (EHR) 中，用于预测心臟衰竭风险，从而实现预防性治疗。日本对数位健康创新的关注正促使医疗科技公司与人工智慧新创公司展开合作，以加速智慧诊断设备的部署。政府对个人化医疗的推动也推动了人工智慧赋能的心血管护理，以便根据基因和生活方式因素制定精准的治疗方案。随着人工智慧减少诊断错误并提高工作流程效率，其在心血管设备中的应用正在不断增加，从而改善了患者管理并节省了长期医疗成本。例如，2024 年 9 月，奥林巴斯在欧洲、亚洲和大洋洲推出了 VISERA S，这是一款具有 NBI 和频闪功能的一体化成像平台，透过改进的可视化和简化的工作流程增强了耳鼻喉诊断。

穿戴式和远端心臟监测设备的扩展

随着日本人口老化和心臟病发病率的上升，穿戴式和远端心臟监测设备正在迅速普及。内建心电图的智慧手錶、手持式动态心电图监测仪和植入式心臟事件记录器正成为预防心臟病学的基石。 5G 连接的出现正在加速即时资料传输，使医生能够远端监测患者并在危急事件发生前发现异常。日本设备製造商正在研发小巧易用、电池续航力更长的穿戴设备，以提高患者依从性。随着日本加快医疗数位化进程，日本药品生产和医疗器材管理局 (PMDA) 的支持正在推动尖端远距医疗解决方案的快速审批。保险公司开始为远端监测服务提供报销，进一步推动了市场扩张。随着诊所和医院部署基于云端的心臟监测系统，在日本不断变化的心血管护理环境中，数据驱动的信息正在最大限度地优化治疗方案，降低再入院率，并改善患者预后。

日本心血管设备市场细分：

设备类型洞察：

  • 诊断和监测设备
    • 心电图（ECG）
    • 远端心臟监测
    • 其他的
  • 治疗及外科手术设备
    • 心律管理 (CRM) 设备
    • 导管
    • 支架
    • 心臟瓣膜
    • 其他的

应用程式洞察：

  • 冠状动脉疾病（CAD）
  • 心律不整
  • 心臟衰竭
  • 其他的

最终用户洞察：

  • 医院
  • 专科诊所
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本心血管设备市场迄今表现如何？未来几年将如何表现？
  • 根据设备类型，日本心血管设备市场是如何分類的？
  • 日本心血管设备市场根据应用如何划分？
  • 根据最终用户，日本心血管设备市场是如何分類的？
  • 日本心血管设备市场的价值链分为哪些阶段？
  • 日本心血管设备的主要驱动因素和挑战是什么？
  • 日本心血管设备市场的结构是怎么样的？主要参与者是谁？
  • 日本心血管设备市场的竞争程度如何？

本报告回答的关键问题：

  • 日本心血管设备市场迄今表现如何？未来几年将如何表现？
  • 根据设备类型，日本心血管设备市场是如何分類的？
  • 日本心血管设备市场根据应用如何划分？
  • 根据最终用户，日本心血管设备市场是如何分類的？
  • 日本心血管设备市场的价值链分为哪些阶段？
  • 日本心血管设备的主要驱动因素和挑战是什么？
  • 日本心血管设备市场的结构是怎么样的？主要参与者是谁？
  • 日本心血管设备市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本心血管设备市场-简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本心血管设备市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本心血管设备市场-细分：依设备类型

  • 诊断和监测设备
    • 概述
    • 市场区隔
      • 心电图（ECG）
      • 远端心臟监测
      • 其他的
  • 治疗及外科手术设备
    • 概述
    • 市场区隔
      • 心律管理 (CRM) 设备
      • 导管
      • 支架
      • 心臟瓣膜
      • 其他的

第七章：日本心血管设备市场-细分：依应用

  • 冠状动脉疾病（CAD）
    • 概述
  • 心律不整
    • 概述
  • 心臟衰竭
    • 概述
  • 其他的

第 8 章：日本心血管设备市场 - 细分：按最终用户

  • 医院
    • 概述
  • 专科诊所
    • 概述
  • 其他的

第九章：日本心血管设备市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章：关键参与者简介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本心血管设备市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112025A32512

The Japan cardiovascular devices market size reached USD 3.30 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7.01 Million by 2033, exhibiting a growth rate (CAGR) of 8.08% during 2025-2033. The market is driven by an aging population, rising cardiovascular diseases, and technological advancements. Key segments include pacemakers, stents, and monitoring devices. Government initiatives and increasing healthcare investments support market growth, while regulatory policies influence product approvals and adoption.

Japan Cardiovascular Devices Market Trends:

Rising Demand for Minimally Invasive Cardiovascular Procedures

Japan is facing a higher demand for minimally invasive (MI) cardiovascular devices owing to an aging population and improved catheter-based treatments. The adoption of transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI) is rising, reducing hospital stays and accelerating recovery. Japanese medical device companies are investing in robotics-assisted procedures and next-generation catheters to improve precision. The regulatory environment, under the guidance of the Pharmaceuticals and Medical Devices Agency (PMDA), is making approval easier for groundbreaking technologies, permitting quicker market entry. Furthermore, artificial intelligence (AI) is improving the precision of cardiovascular imaging diagnostics, aiding early intervention protocols. For example, in September 2024, Japan-based Cardio Intelligence introduced SmartRobin AI, an ECG monitoring system powered by explainable AI for fast atrial fibrillation detection, enhancing stroke risk assessment and diagnostic accuracy in cardiovascular care. Additionally, with home healthcare being supported by the government, remote monitoring devices such as wearable ECGs and implantable loop recorders are also becoming popular. The trend is in support of Japan's value-based medicine drive, stressing cost-effectiveness and patient outcome. With shifting reimbursement policies, the market can anticipate increased growth in minimally invasive cardiovascular solutions.

Growth of AI-Integrated Cardiovascular Diagnostics

AI is transforming cardiovascular diagnostics in Japan, improving early disease detection and predictive analytics. AI-driven echocardiography and computed tomography (CT) imaging machines are enabling faster, more accurate diagnosis of heart disease. Large research centers and hospitals are applying AI in real-time monitoring of the heart, reducing the burden on healthcare personnel. ML technologies are being integrated into electronic health records (EHRs) for predicting risks of heart failure, allowing preventive treatment modalities. The focus on digital health innovation in Japan is inducing collaborations between medtech firms and AI startups to accelerate the deployment of intelligent diagnostic equipment. The government drive in personalized medicine is also driving AI-enabled cardiovascular care so that precise treatment plans are delivered based on gene and lifestyle factors. As AI reduces diagnostic errors and increases workflow efficiency, its use in cardiovascular devices is increasing, leading to improved patient management and long-term healthcare cost savings. For instance, in September 2024, Olympus launched VISERA S, an all-in-one imaging platform with NBI and stroboscopy, across Europe, Asia, and Oceania, enhancing ENT diagnostics with improved visualization and streamlined workflow.

Expansion of Wearable and Remote Cardiac Monitoring Devices

Wearable and remote cardiac monitoring devices are gaining quick adoption in Japan, fueled by the increasing age population and the rising incidence of heart diseases. Smartwatches with built-in ECG, hand-carried Holter monitors, and implantable cardiac event recorders are becoming cornerstones of preventive cardiology. The emergence of 5G connectivity is accelerating real-time data transmission, allowing doctors to monitor patients remotely and catch anomalies before critical events. Japanese device makers are creating small, easy-to-use wearables with longer battery life to drive patient compliance. PMDA support is driving speedy approvals of cutting-edge telemedicine solutions as the nation accelerates healthcare digitalization. Insurers are starting to reimburse for remote monitoring services, further driving market expansion. As clinics and hospitals implement cloud-based cardiac monitoring systems, data-driven information is maximizing treatment plans, lowering hospital readmissions, and enhancing patient outcomes in Japan's changing cardiovascular care environment.

Japan Cardiovascular Devices Market Segmentation:

Device Type Insights:

  • Diagnostic and Monitoring Devices
    • Electrocardiogram (ECG)
    • Remote Cardiac Monitoring
    • Others
  • Therapeutic and Surgical Devices
    • Cardiac Rhythm Management (CRM) Devices
    • Catheter
    • Stents
    • Heart Valves
    • Others

Application Insights:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan cardiovascular devices market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan cardiovascular devices market on the basis of device type?
  • What is the breakup of the Japan cardiovascular devices market on the basis of application?
  • What is the breakup of the Japan cardiovascular devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan cardiovascular devices market?
  • What are the key driving factors and challenges in the Japan cardiovascular devices?
  • What is the structure of the Japan cardiovascular devices market and who are the key players?
  • What is the degree of competition in the Japan cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cardiovascular Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Cardiovascular Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Cardiovascular Devices Market - Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Electrocardiogram (ECG)
      • 6.1.3.2 Remote Cardiac Monitoring
      • 6.1.3.3 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.3.2 Catheter
      • 6.2.3.3 Stents
      • 6.2.3.4 Heart Valves
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Cardiovascular Devices Market - Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Heart Failure
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2019-2024)
    • 7.4.2 Market Forecast (2025-2033)

8 Japan Cardiovascular Devices Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2019-2024)
    • 8.3.2 Market Forecast (2025-2033)

9 Japan Cardiovascular Devices Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Cardiovascular Devices Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix